Cite
HARVARD Citation
Fedirko, V. et al. (2017). Plasma lipoxin A4 and resolvin D1 are not associated with reduced adenoma risk in a randomized trial of aspirin to prevent colon adenomas. Molecular carcinogenesis. 56 (8), pp. 1977-1983. [Online].